{"id":814014,"date":"2025-02-18T08:06:45","date_gmt":"2025-02-18T13:06:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/"},"modified":"2025-02-18T08:06:45","modified_gmt":"2025-02-18T13:06:45","slug":"establishment-labs-launches-preserve","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/","title":{"rendered":"Establishment Labs Launches Preserv\u00e9\u2122"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\">\nEstablishment Labs Launches Preserv\u00e9\u2122\n<\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women\u2019s health and wellness in breast aesthetics and reconstruction, announced it has launched Preserv\u00e9\u2122 in Brazil, the first country in its global rollout. Preserv\u00e9 is the second product in the Company\u2019s minimally invasive platform, building upon the technologies and techniques developed with Mia Femtech<sup>\u00ae<\/sup>, Establishment Labs\u2019 minimally invasive experience.\n<\/p>\n<p>\n\u201cThese are not small innovations, this is an entirely new era for aesthetic breast surgery,\u201d said Juan Jos\u00e9 Chac\u00f3n-Quir\u00f3s, Founder and CEO of Establishment Labs. \u201cWhereas Mia<sup>\u00ae<\/sup> made minimally invasive breast aesthetics possible for women looking for a one to two cup enhancement, Preserv\u00e9 allows less invasive breast surgery for the day-to-day breast augmentation patient.\u201d\n<\/p>\n<p>\n\u201cHistorically, many women have not been convinced by traditional methods and legacy techniques,\u201d Mr. Chac\u00f3n-Quir\u00f3s continued. \u201cWith Mia and Preserv\u00e9, we have solutions that address these concerns. The technology platform of breast tissue preservation allows plastic surgeons to create natural results with less disruption of the patient\u2019s breast tissue. By improving safety profiles, recovery times, and achieving the breast aesthetic patients are looking for, breast augmentation may now be possible for women that otherwise never would have considered it \u2014 as well as making the decision easier for many who were already considering. After Brazil, Preserv\u00e9 will rollout globally over the next few years, and this should contribute to top line growth and profitability.\u201d\n<\/p>\n<p>\nPreserv\u00e9 was designed to preserve breast tissue during aesthetic breast surgery, maintaining the structural anatomy and function of the breast for more stable and natural outcomes when compared to traditional breast augmentation. Preserv\u00e9 leverages Establishment Labs\u2019 proprietary minimally invasive surgical tools coupled with the Ergonomix2 implants, which feature the patented SmoothSilk\u00ae surface, designed for enhanced biocompatibility and softness, and which are unique in the industry as their shape adapts as the body changes position. Preserv\u00e9 is intended for primary augmentations up to four cups, hybrid augmentations, and mastopexy augmentations.\n<\/p>\n<p>\n\u201cBreast tissue preservation is a new paradigm in breast aesthetics. With less invasive breast procedures made possible by technology pioneered by Establishment Labs, we can address many of the complications that lead to reoperations,\u201d said Dr Kamakshi Zeidler, San Francisco plastic surgeon and head of the Femtech board of Establishment Labs. \u201cPreserv\u00e9 is an incredible new choice for women considering breast augmentation because it speaks to many of their aspirations, including smaller scars, quicker recovery, maintaining breast sensation, and avoiding unnecessary reoperations.\u201d\n<\/p>\n<p>\nThe commercial launch of Preserv\u00e9 took place last weekend at the Brazilian Breast Meeting in Rio de Janeiro with over 300 surgeons in attendance and included live surgery and academic sessions. This year additional launches of Preserv\u00e9 are planned around the world.\n<\/p>\n<p>\nThe medical devices used in Preserv\u00e9 are not yet approved for commercial distribution in the United States.\n<\/p>\n<p><span class=\"bwuline\">About Establishment Labs<\/span><\/p>\n<p>\nEstablishment Labs Holdings Inc. is a global medical device company dedicated to improving women\u2019s health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfolio of solutions for breast health, breast aesthetics, and breast reconstruction in over 90 countries. With over four million Motiva \u00ae devices delivered to plastic and reconstructive surgeons since 2010, the Company\u2019s products have created a new standard for safety and patient satisfaction. The company\u2019s minimally invasive platform consists of Mia Femtech\u00ae, a unique minimally invasive experience for breast harmonization, and Preserv\u00e9\u2122, a breast tissue preserving and minimally invasive technology for breast augmentation, revision augmentation and mastopexy augmentation. GEM\u00ae is a next generation minimally invasive system for gluteal ergonomic modeling currently undergoing an IRB approved pivotal study. The Motiva Flora\u00ae tissue expander is used to improve outcomes in breast reconstruction following breast cancer and is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Zensor\u2122 is an RFID technology platform used to safely identify implantable devices from outside the body, and includes the company\u2019s first biosensor Zen\u00ba\u2122, currently part of an IRB approved pivotal study to measure core breast temperature. These solutions are supported by over 200 patents applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in Costa Rica compliant with all applicable regulatory standards under ISO13485:2024 and FDA 21 CFR 820. Please visit our website for additional information at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.establishmentlabs.com&amp;esheet=54208665&amp;newsitemid=20250218369358&amp;lan=en-US&amp;anchor=www.establishmentlabs.com&amp;index=1&amp;md5=5120835fd363234f5346999c4441bb07\">www.establishmentlabs.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250218369358\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250218369358\/en\/<\/a><\/span><\/p>\n<p>\nInvestor\/Media Contact:<br \/>\n<br \/>Raj Denhoy<br \/>\n<br \/>415-828-1044<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:rdenhoy@establishmentlabs.com\">rdenhoy@establishmentlabs.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Latin America North America United States Brazil South America New York<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Surgery Medical Devices Women Public Relations\/Investor Relations Communications Health Technology Health Consumer General Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250218369358\/en\/2384628\/3\/Logo_ESTA_RGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Establishment Labs Launches Preserv\u00e9\u2122 NEW YORK&#8211;(BUSINESS WIRE)&#8211; Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women\u2019s health and wellness in breast aesthetics and reconstruction, announced it has launched Preserv\u00e9\u2122 in Brazil, the first country in its global rollout. Preserv\u00e9 is the second product in the Company\u2019s minimally invasive platform, building upon the technologies and techniques developed with Mia Femtech\u00ae, Establishment Labs\u2019 minimally invasive experience. \u201cThese are not small innovations, this is an entirely new era for aesthetic breast surgery,\u201d said Juan Jos\u00e9 Chac\u00f3n-Quir\u00f3s, Founder and CEO of Establishment Labs. \u201cWhereas Mia\u00ae made minimally invasive breast aesthetics possible for women looking for a one to two cup enhancement, Preserv\u00e9 allows less invasive breast surgery for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Establishment Labs Launches Preserv\u00e9\u2122&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-814014","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Establishment Labs Launches Preserv\u00e9\u2122 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Establishment Labs Launches Preserv\u00e9\u2122 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Establishment Labs Launches Preserv\u00e9\u2122 NEW YORK&#8211;(BUSINESS WIRE)&#8211; Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women\u2019s health and wellness in breast aesthetics and reconstruction, announced it has launched Preserv\u00e9\u2122 in Brazil, the first country in its global rollout. Preserv\u00e9 is the second product in the Company\u2019s minimally invasive platform, building upon the technologies and techniques developed with Mia Femtech\u00ae, Establishment Labs\u2019 minimally invasive experience. \u201cThese are not small innovations, this is an entirely new era for aesthetic breast surgery,\u201d said Juan Jos\u00e9 Chac\u00f3n-Quir\u00f3s, Founder and CEO of Establishment Labs. \u201cWhereas Mia\u00ae made minimally invasive breast aesthetics possible for women looking for a one to two cup enhancement, Preserv\u00e9 allows less invasive breast surgery for &hellip; Continue reading &quot;Establishment Labs Launches Preserv\u00e9\u2122&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-18T13:06:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Establishment Labs Launches Preserv\u00e9\u2122\",\"datePublished\":\"2025-02-18T13:06:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/\"},\"wordCount\":797,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/\",\"name\":\"Establishment Labs Launches Preserv\u00e9\u2122 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-02-18T13:06:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-launches-preserve\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Establishment Labs Launches Preserv\u00e9\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Establishment Labs Launches Preserv\u00e9\u2122 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/","og_locale":"en_US","og_type":"article","og_title":"Establishment Labs Launches Preserv\u00e9\u2122 - Market Newsdesk","og_description":"Establishment Labs Launches Preserv\u00e9\u2122 NEW YORK&#8211;(BUSINESS WIRE)&#8211; Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women\u2019s health and wellness in breast aesthetics and reconstruction, announced it has launched Preserv\u00e9\u2122 in Brazil, the first country in its global rollout. Preserv\u00e9 is the second product in the Company\u2019s minimally invasive platform, building upon the technologies and techniques developed with Mia Femtech\u00ae, Establishment Labs\u2019 minimally invasive experience. \u201cThese are not small innovations, this is an entirely new era for aesthetic breast surgery,\u201d said Juan Jos\u00e9 Chac\u00f3n-Quir\u00f3s, Founder and CEO of Establishment Labs. \u201cWhereas Mia\u00ae made minimally invasive breast aesthetics possible for women looking for a one to two cup enhancement, Preserv\u00e9 allows less invasive breast surgery for &hellip; Continue reading \"Establishment Labs Launches Preserv\u00e9\u2122\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-18T13:06:45+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Establishment Labs Launches Preserv\u00e9\u2122","datePublished":"2025-02-18T13:06:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/"},"wordCount":797,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/","name":"Establishment Labs Launches Preserv\u00e9\u2122 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-02-18T13:06:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250218369358r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-launches-preserve\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Establishment Labs Launches Preserv\u00e9\u2122"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=814014"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814014\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=814014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=814014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=814014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}